Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enzon Pharmaceuticals Inc (OTCQX US:ENZN)

0.3711
Delayed Data
As of Aug 18
 -0.0089 / -2.33%
Today’s Change
0.22
Today|||52-Week Range
0.39
+1.68%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Revenue and IncomeNet Revenues2.0M853.0K1.4M6.8M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses376.0K146.0K349.0K337.0K
 
 
 
 
 
Total Operating Expenses376.0K146.0K349.0K337.0K
 
 
 
 
 
 
Non-Operating ExpensesOperating Income1.6M707.0K1.1M6.4M
 
 
 
 
 
Extraordinary Charge0.00-54.0K0.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income1.6M653.0K1.1M6.4M
 
 
 
 
 
Income Taxes-674.0K-5.3M-446.0K-2.3M
 
 
 
 
 
Net Income936.0K-4.6M645.0K4.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS44.2M44.2M44.2M44.2M
 
 
 
 
 
Shares To Calculate EPS Diluted44.2M44.2M44.2M44.2M
 
 
 
 
 
 
Earnings Per ShareEPS$0.02-$0.11$0.01$0.09
 
 
 
 
 
EPS Diluted$0.02-$0.10$0.01$0.09